Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) EBT Margin (2016 - 2025)

Historic EBT Margin for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to 33.72%.

  • Utah Medical Products' EBT Margin fell 80500.0% to 33.72% in Q3 2025 from the same period last year, while for Sep 2025 it was 37.84%, marking a year-over-year decrease of 34700.0%. This contributed to the annual value of 41.08% for FY2024, which is 10800.0% up from last year.
  • Per Utah Medical Products' latest filing, its EBT Margin stood at 33.72% for Q3 2025, which was down 80500.0% from 38.54% recorded in Q2 2025.
  • Utah Medical Products' EBT Margin's 5-year high stood at 42.31% during Q1 2024, with a 5-year trough of 33.72% in Q3 2025.
  • Over the past 5 years, Utah Medical Products' median EBT Margin value was 40.12% (recorded in 2021), while the average stood at 39.41%.
  • In the last 5 years, Utah Medical Products' EBT Margin soared by 157800bps in 2021 and then crashed by -80500bps in 2025.
  • Utah Medical Products' EBT Margin (Quarter) stood at 40.12% in 2021, then rose by 3bps to 41.19% in 2022, then fell by -1bps to 40.68% in 2023, then fell by -3bps to 39.47% in 2024, then decreased by -15bps to 33.72% in 2025.
  • Its EBT Margin was 33.72% in Q3 2025, compared to 38.54% in Q2 2025 and 39.73% in Q1 2025.